Menu
GeneBe

19-41860777-G-C

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_001022.4(RPS19):c.3G>C(p.Met1?) variant causes a start lost, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 33)

Consequence

RPS19
NM_001022.4 start_lost, splice_region

Scores

8
3
1

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 6.90
Variant links:
Genes affected
RPS19 (HGNC:10402): (ribosomal protein S19) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S19E family of ribosomal proteins. It is located in the cytoplasm. Mutations in this gene cause Diamond-Blackfan anemia (DBA), a constitutional erythroblastopenia characterized by absent or decreased erythroid precursors, in a subset of patients. This suggests a possible extra-ribosomal function for this gene in erythropoietic differentiation and proliferation, in addition to its ribosomal function. Higher expression levels of this gene in some primary colon carcinomas compared to matched normal colon tissues has been observed. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-41860777-G-C is Pathogenic according to our data. Variant chr19-41860777-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 1736908.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr19-41860777-G-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RPS19NM_001022.4 linkuse as main transcriptc.3G>C p.Met1? start_lost, splice_region_variant 2/6 ENST00000598742.6
RPS19NM_001321485.2 linkuse as main transcriptc.3G>C p.Met1? start_lost, splice_region_variant 2/6
RPS19NM_001321483.2 linkuse as main transcriptc.3G>C p.Met1? start_lost, splice_region_variant 2/6
RPS19NM_001321484.2 linkuse as main transcriptc.3G>C p.Met1? start_lost, splice_region_variant 2/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RPS19ENST00000598742.6 linkuse as main transcriptc.3G>C p.Met1? start_lost, splice_region_variant 2/61 NM_001022.4 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Diamond-Blackfan anemia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsAug 04, 2016The p.M1? pathogenic mutation (also known as c.3G>C) is located in coding exon 1 of the RPS19 gene and results from a G to C substitution at nucleotide position 3. This alters the methionine residue at the initiation codon. This mutation was reported as a de novo occurrence in a patient with a clinical diagnosis of Diamond-Blackfan Anemia. The same study also described another affected individual with a mutation at the same codon (Ramenghi U et al. Blood Cells Mol. Dis., 2000 Oct;26:417-22). In addition to the clinical data presented in the literature, since sequence variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Pathogenic
0.58
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.76
D;.;D;.;D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
D
Sift4G
Uncertain
0.0050
D;D;D;D;D
Polyphen
1.0
D;.;D;.;D
Vest4
0.98
MutPred
1.0
Gain of catalytic residue at M1 (P = 0.0182);Gain of catalytic residue at M1 (P = 0.0182);Gain of catalytic residue at M1 (P = 0.0182);Gain of catalytic residue at M1 (P = 0.0182);Gain of catalytic residue at M1 (P = 0.0182);
MVP
0.94
ClinPred
1.0
D
GERP RS
4.5
Varity_R
0.70
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-42364847; API